Skip to main content
Kiniksa Pharmaceuticals, Ltd. (KNSA)
NASDAQ: KNSA · IEX Real-Time Price · USD
19.67
-0.10 (-0.51%)
May 20, 2024, 4:00 PM EDT - Market closed

Kiniksa Pharmaceuticals Revenue

Kiniksa Pharmaceuticals had revenue of $301.77M in the twelve months ending March 31, 2024, with 27.69% growth year-over-year. Revenue in the quarter ending March 31, 2024 was $79.86M with 65.18% year-over-year growth. In the year 2023, Kiniksa Pharmaceuticals had annual revenue of $270.26M with 22.74% growth.

Revenue (ttm)
$301.77M
Revenue Growth
+27.69%
P/S Ratio
4.62
Revenue / Employee
$1,016,067
Employees
297
Market Cap
1.40B USD

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 2023270.26M50.08M22.74%
Dec 31, 2022220.18M181.64M471.24%
Dec 31, 202138.54M--
Dec 31, 20200--
Dec 31, 20190--
Dec 31, 20180--
Dec 31, 20170--
Dec 31, 20160--
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Owens & Minor 10.42B
Alignment Healthcare 2.01B
Omnicell 1.10B
Pacira BioSciences 681.75M
Phreesia 356.30M
Xencor 162.18M
Tarsus Pharmaceuticals 42.56M
Revenue Rankings

KNSA News

More News